The 39th European Association of Urology (EAU) Congress/Annual Meeting
2024 was successfully held on April 5 to 8, 2024 in Paris France. The EAU Congress
is the largest and most influential academic meeting on urology in Europe, with
more than 15,000 urologists and related professionals from over 110 countries
around the world expected to attend.
In this EAU France urology annual meeting, Leapmed's latest technology:
prostate biopsy kit, was widely noticed and praised by the attendees. The sales
staffs made professional technical introduction and on-site answer to the product,
which provides the attendees with the deep insight into Leapmed's products.
Many visitors showed great interest in our products and technologies, and actively
communicated with us to sought for further cooperation. By communicating with
them, we not only collected valuable industry information, but also established a
wide range of contacts. In addition, we also actively participated in several
communication activities organized by the conference to further expand the
influence of our company.
Prostate Biopsy Guide
Prostate Guide-X disposable transperineal biopsy guide + full automatic
biopsy instrument adapts to a variety of biplane ultrasound probe such as 8848,
U533, and TRT33. The product is easy to install with fixing button allowing oneclick
locking. Its innovative semi-open needle groove can improve efficiency by
quick sorting of the biopsy instrument.
We gained valuable experience through this exhibition. Interaction with
attendees is the key to enhance brand awareness and get market feedback.
Besides, we will adjust and optimize our products and services according to
market feedback and customer needs, so as to be fully prepared for future
cooperation.
The experience of exhibiting at the EAU France Annual Urology Congress is a
valuable experience for us. We not only realized our exhibition goals, but also
gained market feedback and cooperation opportunities. In the future, we will
make continuous efforts to improve our brand inϐluence and service level to
make greater contributions to urological health development.
